A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
Clinical trial NCT02713282 · COMPLETED
Trial details
- NCT number
- NCT02713282
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-28
- Primary completion
- 2018-03-26
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.